01 1Aurobindo Pharma Limited
02 1Merck Sharp & Dohme Corp.
03 1Savior Lifetec Corporation
01 3Ertapenem Sodium
01 1India
02 1Taiwan
03 1U.S.A
NDC Package Code : 59651-190
Start Marketing Date : 2023-12-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69806-0003
Start Marketing Date : 2001-11-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : EXPORT ONLY
NDC Package Code : 44647-005
Start Marketing Date : 2020-05-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (5kg/5kg)
Marketing Category : BULK INGREDIENT
A Ertapenem Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ertapenem Sodium, including repackagers and relabelers. The FDA regulates Ertapenem Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ertapenem Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ertapenem Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ertapenem Sodium supplier is an individual or a company that provides Ertapenem Sodium active pharmaceutical ingredient (API) or Ertapenem Sodium finished formulations upon request. The Ertapenem Sodium suppliers may include Ertapenem Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Ertapenem Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ertapenem Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ertapenem Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ertapenem Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ertapenem Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ertapenem Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ertapenem Sodium suppliers with NDC on PharmaCompass.
We have 3 companies offering Ertapenem Sodium
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
